AKT1 and non-small cell lung carcinoma: Similarly, another study28 showed that NTN1 interference promotes EMT via the PI3K/AKT pathway in the hypoxic microenvironment of NSCLC, suggesting that plasma NTN1 could be used as a diagnostic and prognostic biomarker in these patients.